Business Standard

Sun Pharma's US arm launches anticancer injection

Image

Press Trust of India New Delhi

Sun Pharmaceutical's US arm Caraco has launched oxaliplatin injections, used in the treatment of cancer, in the American market.

These oxaliplatin injections have been introduced in 50 mg and 100 mg strength after approval from US Food and Drug Administration, Caraco said in a statement.

Oxaliplatin is an anticancer used in the treatment of colon and rectal cancer. These injections have annual sales of about $1.3 billion in America.

Detroit-based Caraco Pharmaceutical Laboratories develops, manufactures, markets generic drugs to wholesalers, distributors and drugstore chains.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 12 2010 | 9:22 PM IST

Explore News